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Abstract
Summary We estimated the number of hip fracture patients in
2012 in Japan and investigated the trends in incidence during a
25-year period from 1987 to 2012. Despite the increasing
number of patients, the incidence of hip fracture in both men
and women aged 70–79 years showed the possibility of
decline.
Introduction The objectives of this study were to estimate the
number of hip fracture patients in 2012, to investigate the
trends in incidence during a 25-year period from 1987 to
2012, and to determine the regional differences in Japan.
Methods Data were collected through a nationwide survey
based on hospitals by a mail-in survey. Hip fracture incidences
by sex and age and standardized incidence ratios by region
were calculated.
Results The estimated numbers of new hip fracture pa-
tients in 2012 were 175,700 in total (95 % CI 170,300–
181,100), 37,600 (36,600–38,600) for men and 138,100
(134,300–141,900) for women. The incidence rates in
both men and women aged 70–79 years were the lowest
in the 20-year period from 1992 to 2012. The incidence
was higher in western areas of Japan than that in eastern
areas in both men and women; however, the difference in
the incidence of hip fracture between western and eastern
areas is becoming smaller.
Conclusions Despite the increasing number of new patients,
the incidence of hip fracture in both men and women aged 70–
79 years showed the possibility of decline. The exact reasons
for this are unknown, but various drugs for improving bone
mineral density or preventing hip fracture might have influ-
enced the results. A decrease in the differences in nutrient
intake levels might explain some of the change in regional
differences in Japan.
Keywords Aging . Drug therapy . Hip fracture . Incidence .
Osteoporosis . Time trends
Introduction
Osteoporosis is a common disease characterized by a sys-
temic impairment of bone mass and microarchitecture that
results in fragility fractures [1]. Osteoporotic fractures are
a frequent and important cause of disability and high
medical costs worldwide [2]. Hip fracture is the most
serious outcome of osteoporosis. In addition to the sub-
stantial cost burden, hip fractures are also associated with
a high mortality rate [3].
The Comprehensive Survey of Living Conditions showed
that fractures and falls accounted for 10 % (7.0 % for men
and 11.7 % for women) of the needs for long-term care [4].
The number of people in Japan who need some support in
daily life or who need in long-term care need is about 5.5
million, an increase of about 1.5 times over the past decade,
and the number has been increasing steadily [5]. Hence, a
variety of countermeasures against hip fracture and
* Y. Yaegashi
yumiyae@iwate-med.ac.jp
1 Kenkoin Clinic, Chuo-ku, Tokyo, Japan
2 Department of Hygiene and Preventive Medicine, School of
Medicine, Iwate Medical University, 2-1-1 Nishitokuta, Yahaba-cho,
Shiwa-gun, Iwate 028-3694, Japan
3 Ministry of Health, Labour and Welfare, Chiyoda-ku, Tokyo, Japan
4 Department of Public Health, Wakayama Medical University,
Wakayama, Japan
Osteoporos Int (2016) 27:1777–1784
DOI 10.1007/s00198-015-3464-8
osteoporosis are urgent medical and social issues in the rap-
idly aging Japanese population.
A nationwide survey in Japan has been implemented ev-
ery 5 years since 1987, and the trend in hip fracture inci-
dence has been reported. The first nationwide survey was
carried out in 1987 to clarify the sex-specific and age-
specific incidences of hip fractures, and the estimated num-
ber of new patients in 1987 was about 53,200 [6]. The
second nationwide survey, using a different method to im-
prove accuracy, was performed in 1992 and the number of
new patients was estimated to be 76, 600 [7]. In the third
nationwide survey, carried out in 1997, the estimated num-
ber of new patients was 92,400 [8]. In the fourth survey in
2002, the estimated number was 117,900 [9]. In the fifth
survey in 2007, the estimated number of new patients was
148,100. The number of new patients with hip fracture in-
creased 2.8-fold in the 20-period from 1987 to 2007 [10].
The objectives of this study were to estimate the number of
patients with hip fracture in 2012, to investigate the trends in
incidence during the 25-year period from 1987 to 2012, and to




For a nationwide estimate
To estimate the number of new hip fracture patients na-
tionwide in the sixth survey in 2012, hospitals and clinics
including or specializing in orthopedics throughout Japan
were divided into 13 strata according to the number of
beds, maintaining comparability with previous surveys.
In Japan, small hospitals with 19 or fewer beds are de-
fined as clinics. All hospitals with 200 beds or more were
included and hospitals with 199 or fewer beds were ran-
domly selected by Neyman’s allocation method [11] to
minimize standard error. In this survey, among 7201 or-
thopedic institutions in Japan, 4165 institutions were se-
lected as sites to investigate a nationwide estimate, using
the same sample size as that in previous surveys (Table 1).
The number of new patients with hip fracture was esti-
mated by the following formula:




where Ni is the number of surveyed institutions in each
stratum, ni is the number of responding institutions in
each stratum, and Pi is the summation of the number of
new patients in each stratum [8].
For regional estimates
Data from 5210 institutions, all hospitals with 20 beds or more
and 282 clinics, were used for regional estimates to improve
estimation accuracy. Data from clinics that had been randomly
selected for the nationwide estimate were used (Table 1).
We calculated regional estimates of hip fracture incidence
dividing the nation to 12 regions from east to west, such as,
Hokkaido, Tohoku, Kanto I, Kanto II, Hokuriku, Tokai, Kinki
I , Kinki II , Chugoku, Shikoku, Kitakyushu, and
Minamikyushu, which was based on the National Health
and Nutrition Survey in Japan.
The standardized incidence ratio was calculated as follows:
Standardized incidence ratio ¼ BX
I  Pð Þ
;
where B is the estimated number of patients in each region, I is
the nationwide incidence of hip fracture by sex and age
groups, and P is the regional population by sex and age
groups.
Incidences by sex and age groups were calculated on the
basis of the estimated number of new patients. This incidence
was multiplied by the population by the sex and age groups in
each region to obtain the expected number of patients. The
ratio of estimated number of patients to expected number was
calculated as the standardized incidence ratio.
Population figures from the 2010 national census were
used to calculate the incidence of hip fracture and the stan-
dardized incidence ratio by region.
Questionnaire
A questionnaire was sent by mail to all participating or select-
ed hospitals and clinics based on hospital data from Wellness
Co., Ltd. We asked for information on the number of new
patients with hip fracture between January 1 and December
31 in 2012 and information on each patient’s sex and age.
Patients that underwent surgery for hip fracture at other insti-
tutions or patients for rehabilitation were excluded to avoid
double counting of new hip fracture patients.
Results
Response rates
For a nationwide estimate, replies were obtained from 2615
institutions, a response rate of 62.8 %. The response rate was
highest (71.3 %) in clinics with less than 19 beds and was
lowest (56.2 %) in hospitals with 20–49 beds. For regional
estimates, replies were obtained from 3170 institutions, a
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response rate of 60.8 % (Table 2). The response rates by re-
gion were 64.4 % in Hokkaido, 63.5 % in Tohoku, 55.3 % in
Kanto I, 57.1 % in Kanto II, 73.4 % in Hokuriku, 58.7 % in
Tokai, 54.4 % in Kinki I, 67.4 % in Kinki II, 63.9 % in
Chugoku and Shikoku, 65.9 % in Kitakyushu, and 66.3 %
in Minamikyushu.
Nationwide estimate
The estimated numbers of new hip fracture patients in 2012
were 175,700 in total (95 % CI 170,300–181,100), 37,600
(36,600–38,600) for men and 138,100 (134,300–141,900)
for women. As shown in Table 3, the number of new patients
in the 2012 survey was 1.2 times larger than that in the 2007
survey [10], and the number of new patients in the 2012 sur-
vey was 3.3 times larger than that in the 1987 survey [6]. The
number of new female patients increased from 39,700 in 1987
to 138,100 in 2012.
The annual incidence rate (per 10,000) of hip fracture
in 2012 was calculated by sex and age (Table 4). The
incidence rates of hip fracture in men and women by
age were 0.29 and 0.14 under 40 years, 1.09 and 0.73 in
40s, 2.23 and 3.13 in 50s, 5.03 and 8.66 in 60s, 16.88 and
36.71 in 70s, 60.81 and 151.03 in 80s, and 159.46 and
323.25 over 90 years, respectively. The incidence rates in
both men and women aged 70–79 years were lowest in
Table 1 Number of institutions
and sampling numbers for a
nationwide estimate and regional
estimates by stratum
Stratum no. No. of beds No. of
institutions
Sampling no. for nationwide
estimate (%)
Sampling no. for regional
estimates (%)
Total 7201 4165 (57.8) 5210 (72.4)
1 −19 2273 282 (12.4) 282 (12.4)
2 20–49 397 162 (40.8) 397 (100)
3 50–99 1219 825 (67.7) 1219 (100)
4 100–149 825 548 (66.4) 825 (100)
5 150–199 773 634 (82.0) 773 (100)
6 200–299 577 577 (100) 577 (100)
7 300–399 492 492 (100) 492 (100)
8 400–499 237 237 (100) 237 (100)
9 500–599 157 157 (100) 157 (100)
10 600–699 105 105 (100) 105 (100)
11 700–799 54 54 (100) 54 (100)
12 800–899 30 30 (100) 30 (100)
13 900+ 62 62 (100) 62 (100)
Table 2 Number of responding institutions and response rates for a nationwide estimate and regional estimates by stratum












Total 4165 2615 62.8 5210 3170 60.8
1 −19 282 201 71.3 282 201 71.3
2 20–49 162 91 56.2 397 228 57.4
3 50–99 825 484 58.7 1219 685 56.2
4 100–149 548 335 61.1 825 475 57.6
5 150–199 634 416 65.6 773 493 63.8
6 200–299 577 348 60.3 577 348 60.3
7 300–399 492 318 64.6 492 318 64.6
8 400–499 237 156 65.8 237 156 65.8
9 500–599 157 93 59.2 157 93 59.2
10 600–699 105 73 69.5 105 73 69.5
11 700–799 54 37 68.5 54 37 68.5
12 800–899 30 19 63.3 30 19 63.3
13 900+ 62 44 71.0 62 44 71.0
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the 20-year period from 1992 to 2012. Figure 1 shows the
ratio of change in incidence rate of hip fracture per 10,
000, 1992–2012. The incidence rates in both men and
women aged 60–79 years tended to decline.
Regional estimates
Figure 2 shows the east-west regional differences
expressed by standardized incidence ratios. Crude inci-
dences of hip fracture per 10,000 by region were high in
men in the western areas of Japan (Chugoku 8.28 per 10,
000, Shikoku 8.17 per 10,000, and Kinki II 7.63 per 10,
000) compared with those in the eastern areas (Kanto I
4.83 per 10,000, Tokai 5.49 per 10,000, and Tohoku 5.81
per 10,000). The pattern in women was similar, with the
highest rates in the western areas of Chugoku (29.75 per
10,000), Kinki II (27.30 per 10,000), and Shikoku (26.95
per 10,000) and lower rates in the eastern areas of Kanto I
(16.66 per 10,000), Tohoku (18.93 per 10,000), and Tokai
(20.01 per 10,000).
Similarity in the patterns for both men and women is note-
worthy. Areas in which the incidence ratio was more than
20 % higher in the incidence ratio were Kinki I for men and
Kinki I and II for women. Areas in which the incidence ratios
were from 10 % to less than 20 % were Kinki II and Chugoku
for men and Chugoku and Kitakyushu for women.
Discussion
The results of our study showed the incidence of hip fracture
in 2012 and the trend in hip fracture over a 25-year period.
The results showed a drastic increase in the number of pa-
tients, especially women. According to data obtained every
5 years, the number of new hip fracture patients has contin-
ued to increase. The total number of hip fracture patients
was 53,200 in 1987, and the number increased markedly
to 175,700 in 2012. The number of female hip fracture pa-
tients was about 3.7 times larger than the number of male
hip fracture patients in 2012, indicating a disparity in sex. It
is clear that the number of new patients increases yearly
because of changes in the national demographic structure.
Between 1985 and 2013, the proportion of people 65 years
of age or over in Japan increased from 10.3 % (12.5 million)
to 25.1 % (31.9 million; 8.6 to 22.1 % in men and 12.0 to
27.8 % in women). The number of people 65 years of age or
over is estimated to increase to 36.6 million in 2025, ac-
counting for more than 30 % of the population of Japan
[12, 13]. A comparison of the aging rate in Japan in 2010
with the rates in other countries shows a considerable dis-
parity: 20.8 % in Germany, 20.3 % in Italy, 18.2 % in
Sweden, 16.8 % in France, 13.1 % in the USA, 11.1 % in
Korea, 8.4 % in China, and 5.1 % in India. The high rate in
Japan in 2010 (23.0 %) is an unprecedented situation [14].
Table 3 Trends in estimated number of new hip fracture patients per year, 1987–2012
1987 1992 1997 2002 2007 2012
Total point estimation 53,200 people 76,600 92,400 117,900 148,100 175,700
(95 % confidence interval) 69,000–84,000 89,900–94,900 114,700–121,100 144,000–152,200 170,300–181,100
5-yr increase (% rate of increase) 23,400 (+44.0 %) 15,800 (+20.6 %) 25,500 (+27.6 %) 30,200 (+25.6 %) 27,600 (+18.6 %)
Men point estimation 13,500 18,700 20,800 25,300 31,300 37,600
(95 % confidence interval) 17,000–21,000 20,100–21,400 24,500–26,000 30,500–32,100 36,600–38,600
5-yr increase (% rate of increase) 5200 (+38.5 %) 2100 (+11.2 %) 4500 (+21.6 %) 6000 (+23.7 %) 6300 (+20.1 %)
Women point estimation 39,700 57,900 71,600 92,600 116,800 138,100
(95 % confidence interval) 52,000–64,000 69,600–73,600 90,000–95,200 113,900–119,700 134,300–141,900
5-yr increase (% rate of increase) 18,200 (+45.8 %) 13,700 (+23.7 %) 21,000 (+29.3 %) 24,200 (+26.1 %) 21,300 (+18.2 %)
Table 4 Incidence rate of hip fracture per 10,000, 1992–2012
1992 1997 2002 2007 2012
Male, age
-39 0.36 0.30 0.30 0.32 0.29
40- 1.03 0.91 0.84 0.92 1.09
50- 2.21 2.00 1.82 2.03 2.23
60- 5.74 5.12 5.26 4.81 5.03
70- 19.13 17.29 17.49 18.12 16.88
80- 56.02 57.41 58.61 61.03 60.81
90- 124.96 128.89 141.39 146.62 159.46
All ages 3.08 3.38 4.08 5.11 6.10
Female, age
-39 0.16 0.13 0.12 0.15 0.14
40- 0.61 0.60 0.58 0.70 0.73
50- 2.82 2.39 2.41 2.95 3.13
60- 9.69 9.07 9.11 8.11 8.66
70- 44.32 40.85 41.07 39.71 36.71
80- 139.60 147.79 156.10 157.14 151.03
90- 264.66 281.04 315.52 313.58 323.25
All ages 9.20 11.19 14.43 18.14 21.31
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The results of the present study showed that the incidence
of hip fracture was higher in western areas than in eastern
areas of Japan for both men and women. This trend has not
changed since 1987, when the first nationwide survey was
carried out. However, the regional difference in incidence of
hip fracture seems to be becoming smaller. According to a
study on associations between hip fracture incidence and in-
take of four nutrients, intake of vitamin K showed a possibility
of contributing to the regional difference more than did intake
of calcium, magnesium, or vitamin D; a high intake of vitamin
K was associated with low incidence of hip fracture, and vice
versa [15]. The ranges of intake of vitamin K over an 11-year
period from 2002 to 2012 have been decreasing in different
areas in Japan; in 2002, 310–320 μg/day in Tohoku and Kanto
areas and 230–255 in Shikoku and Kyushu; in 2012, 238–
261 μg/day in Tohoku and Kanto areas and 206–222 in
Shikoku and Kyushu. The regional differences in the ranges
of vitamin K intake were 90 in 2002 and 55 in 2012 [16, 17].
Although the levels of vitamin K intake in the areas were
different over the past decade, the range of difference is clearly
decreasing. Therefore, the change of regional differences
might be partly due to decreases in the differences in intake
levels of nutrients by area.
In light of intake of nutrients for bone health, we should
reassess our daily lives as well as relying on medicinal bene-
fits such as a variety of bisphosphonates. According to the
National Health and Nutrition Survey of Japan, intake of cal-
cium was substantially below the recommended amount in
each age group. In 2014, mean values of calcium intake were
about 520 mg/day for men and 489 mg/day for women,
Ratio of change in incidence rate of 
hip fracture per 10,000,1992-2012
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though the recommended values are 650–800 mg/day for men
and 650 mg/day for women [18]. Attention should be given to
not only the effects of drugs but also the role of nutritional
factors such as calcium, vitamin K, and vitamin D in bone
health.
A study of hip fracture incidence and probability of fracture
worldwide showed a greater than 10-fold variation in hip frac-
ture risk and fracture probability between countries, based on
the results of a total of 72 studies from 63 countries. In three
categories of age-standardized annual incidence in women,
Denmark, Sweden, Austria, and Norway were in the high
group, Finland, France, Canada, and Japan were in the mod-
erate group, and Brazil, China, South Arica, and Nigeria were
in the low group [19]. According to the first study in which a
direct comparison was made of incidence rates of hip/femur
fractures in the period 2003–2009 in five European countries
including Denmark, the Netherlands, Germany, Spain, and the
UK, incidence rates in people over 50 years of age were two to
three times higher in Denmark than in other countries.
However, only Denmark showed a consistent decline in both
males and females aged 70 years or older [20]. A study in
Germany, based on data from the national hospital discharge
register in 1995–2010, showed that the incidence of hip frac-
ture in women aged 60 years or older decreased or remained
constant. The decline in the incidence of hip fracture in wom-
en was suggested to be due to programs for prevention of falls
and fractures in the elderly, particularly in elderly women in
long-term care facilities [21]. A study in Spain, based on data
from national hospital discharges nationwide, in which two 4-
year periods (1997–2000 and 2007–2010) were compared,
showed a decrease in age-adjusted rates in the second period
(2007–2010) in women, even though the crude incidence in-
creased. Possible causes for the change are intrinsic factors,
changes in lifestyle, and also the use of drug therapy and the
implementation of strategies to prevent falls and osteoporotic
fractures [22]. A study in Italy, in which there is progressive
aging of the population as in Japan, based on data from na-
tional hospitalization records in 2000–2009 showed that a
decreasing trend had started in women aged 65–74 years.
The reduction in women aged 65–74 years might already be
an effect of the awareness about the treatment of osteoporosis
since the beginning of the millennium [23]. A study conduct-
ed from 1970 to 2010 in Finland showed that the number of
hip fractures rose sharply until the end of the 1990s and also
the age-adjusted incidence of hip fracture increased until
1997. However, the incidence declined after 1997, especially
in women, and the declining trend has continued through the
first decade of this century. Possible reasons for the decline
include increased average body weight, improved functional
ability among elderly people, and specific measures to reduce
the risk of falling [24]. A study in the USA, based on data from
national hospital discharge surveys in 1990–2006, showed
that age-adjusted hip fracture rates for both men and women
declined significantly from 1990 to 2006. The reasons for this
trend were suggested to be BMD screening and osteoporosis
treatment, cohort effect of a healthier aging population, im-
proved nutrition, and decreased use of psychoactive drugs to
decrease fall risk, although there are still unknown protective
factors [25]. A recent study in the USA, based on the same
data in 1990–2010, suggested that the expected increase in the
total number of hip fractures will be largely offset by decreas-
ing hip fracture rates among women, although the number of
elderly people in the USA will increase appreciably over the
next 20 years. It also stated in that report that there is a need for
preventive measures against hip fractures in men [26].
In European countries, the USA and Canada, a fracture
liaison service (FLS) has been used to prevent subsequent
fractures. An FLS is a multidisciplinary system approach to
reducing subsequent fracture risk in patients with a recent
fragility fracture by identifying them at or proximate to the
time they are treated at the hospital for fracture and providing
them with easy access to osteoporosis care. The establishment
of an FLS to identify and treat patients with a recent fragility
fracture has been shown to be effective, to save money, to be
useful for documenting high quality of care, and to make good
clinical sense [27].
In an observational study about invitation to an FLS in the
Netherlands, it was shown that about half of the patients
responded but that half of them did not respond because of
lack of interest or being physically unable to attend the clinic.
As a result, after 12 months of follow-up, 88 % of the patients
persisted with anti-osteoporosis therapy and only 2 % suffered
a subsequent clinical fracture. In elderly fracture patients, the
use of an FLS leads to an increased response rate, a high rate
of persistence in drug treatment, and a low rate of subsequent
clinical fractures. For patients that do no respond to an FLS,
additional approaches are required [28]. In another study in
the Netherlands, patients who visited an FLS had a signifi-
cantly lower mortality rate and subsequently a lower risk of
non-vertebral fracture than did patients who did not visit an
FLS. The results showed that an FLS might be a successful
approach to reduce the number of subsequent fractures and
premature mortality [29]. Moreover, a study in the USA in
which the cost-effectiveness of an FLS compared with that
of usual care was examined showed and found that under base
case assumptions, the FLS reduced fractures, increased
quality-adjusted life years, and reduced costs [30].
In 2012, the Japan Osteoporosis Society established an
osteoporosis liaison service (OLS) and held several work-
shops. The main purposes of the OLS are to encourage pa-
tients at high risk for fractures to receive osteoporosis treat-
ment and to increase the persistence rate of osteoporosis treat-
ment in order to decrease the fracture risk and incidence rate of
hip fracture. A certified osteoporosis manager works as a co-
ordinator in a community, clinics, or hospitals, and the OLS
medical staff are actively involved in osteoporosis treatment
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and encourage patients to continue the treatment. There will
be more than 600 certified managers in Japan in the near
future, and this approach might contribute to a decrease of
hip fractures in Japan. In addition to the OLS, instructors for
fall prevention and coordinators for locomotive syndrome,
which according to the Japanese Orthopedic Association is a
high-risk status due to reduced functioning of locomotor ap-
paratuses, work together for both primary and secondary pre-
vention of osteoporosis and hip fracture.
In Japan, first bisphosphonate has been used since 1996,
and then a second-generation bisphosphonate, alendronate
daily was launched in 2001 and a third-generation bisphos-
phonate, risedronate daily in 2002. Their weekly formulations
were approved in 2007 and 2008, respectively, and became
the first-line medications as in European countries, North
America and Oceania. In our previous study on hip fracture
incidence in 2007 and the trend for 20 years, we showed that
the incidences of hip fractures in 2007 were lowest in men
aged 60–69 years and in women aged 60–79 years in a 15-
year period from 1992 to 2007. A possible reason for this is,
we considered, that persons 60–70 years old with osteoporosis
might have come tomedical attention and been treated aggres-
sively [10]. In the present study, we found that the incidence
rates in both men and women aged 70–79 years were the
lowest in the 20-year period from 1992 to 2012. The use of
a wide variety of drugs, especially bisphosphonates, for oste-
oporosis treatment and prevention of hip fracture might have
caused the decrease.
Frequencies of administration of these bisphosphonates are
drastically changing to monthly or weekly administration
from daily administration. In Japan, monthly oral formulation
for minodronate was launched in 2011 and risedronate in
2013. A recent study showed a strong patient preference for
and convenience of a monthly bisphosphonate regimen over a
weekly bisphosphonate regimen among Japanese patients
with osteoporosis [31]. Visiting hospitals or clinics to receive
an intravenous injection or drip of a bisphosphonate monthly
may improve treatment adherence. Recently, monthly injec-
tion and drip formulation became available in Japan and they
might enable treatment of osteoporosis for patients who have
difficulty in taking medicine orally because of other diseases.
Bisphosphonates have been used in many developed coun-
tries as first-line therapy for treatment of most patients with
osteoporosis. While the use of bisphosphonates has resulted in
a significant decrease in morbidity, risks such as osteonecrosis
of the jaw and atypical femur fractures and also drug holidays
have to be considered [32]. Two recent reports in Norway
showed a decreasing hip fracture incidence in Oslo in 2007
and the incidence for the years 2008 to 2010 compared with
that for the years 1998 to 2003 in southeastern Norway [33,
34]. The study conducted in Oslo which has the highest hip
fracture rate in the world showed a significant decrease in age-
adjusted incidence rates for women in 2007 and it was
suggested that bisphosphonate use might be part of the reason
for the decline. It was est imated that the use of
bisphosphonates may explain up to 13 % of the decline in
incidence in women aged 60–69 years and up to 34 % in
women aged 70–79 years [33]. The other study in southeast-
ern Norway showed that the incidence of hip fracture in the
years 2008 to 2010 was similar to that in the years 1998 to
2003. The rate of bisphosphonate use did not exceed 2 % in
any of the groups for men, and the highest rate was 12.6 % in
the group of women aged 85–89 years. Although bisphospho-
nate drugs have been prevalent since the late 1990s, it is dif-
ficult to determine their effectiveness [34]. A study in
Australia suggested that the decline in hip fracture rates was
largely due to the use of bisphosphonates, although there was
no clear understanding of factors related to change in the ep-
idemiology of the incidence of hip fracture. A decline in the
use of bisphosphonates was shown to be associated with an
increase in hip fracture rates in females, indicating that
bisphosphonates should still be considered as first-line medi-
cations for the prevention and treatment of osteoporosis [35].
Another study in Spain showed that a substantial increase in
bisphosphonate use from 2002 to 2008 was weakly but sig-
nificantly correlated with a drop (2.2 %) in standardized hip
fracture rates in women. It was also stated that factors includ-
ing lifestyle advice, health campaigns, self-awareness, im-
provement in residence conditions, and dietetic changes could
partially explain the decline in hip fracture rates [36].
Our study has several limitations. First, we used the mail-in
method because we do not have a nationwide computer-based
register system of hip fractures. At present, this is the best way
to obtain information on hip fractures as a nationwide survey.
In order to receive as many responses as possible, we asked
for responses three times. Moreover, we dealt with questions
from institutions by telephone. Second, although we asked
institutions not to include patients that underwent surgery for
hip fracture at other institutions or patients for rehabilitation, it
was not possible to check them. Third, since we collected data
for all hip fracture patients together, it was not possible to
distinguish between fractures caused by primary osteoporosis
and those caused by secondary osteoporosis. It was also im-
possible to analyze data by types of hip fracture.
In conclusion, despite the increasing number of new pa-
tients, the incidence of hip fracture in both men and women
aged 70–79 years showed the possibility of decline. The exact
reasons for this are unknown, but various kinds of drugs for
improving bone mineral density or preventing hip fracture
might have contributed to the results. A decrease in the differ-
ences of nutrient intake levels might explain some of the
change in regional differences in Japan. Comprehensive coun-
termeasures including drug therapy, cooperation among the
OLS medical staff, instructors for fall prevention and coordi-
nators for locomotive syndrome, and adequate nutritional in-
take will be key factors for hip fracture prevention.
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